Effect of COV2 vaccine formulation on the ability to generate antibodies against coronavirus
Viruses can change over time, so scientists regularly work to update and improve vaccines. This clinical trial tests a new booster vaccine formulation against COVID-19. It is an early-stage study, known as a Phase I trial, which focuses on safety and how the human body reacts to the vaccine. The main goal is to measure how effectively this booster recipe triggers the body to make antibodies. Antibodies are natural proteins in your blood that recognise and fight off infections. By testing this vaccine, researchers hope to see if it creates strong, reliable defence against coronavirus. The study welcomes adults aged 18 and older of any sex. Taking part usually involves getting a booster injection, attending scheduled clinic visits, and giving blood samples so scientists can track immune response and check for any side effects.
At a glance
What is this study about?
COVID-19 vaccines have helped protect millions of people across the UK from severe illness. However, because viruses change, scientists must test new vaccine recipes to keep our defences strong. This study is testing an updated booster formulation to see how well it works and how safe it is.
This is a Phase I trial, which means it is one of the earliest steps in testing a medicine in humans. Researchers will carefully monitor participants after they receive the injection. They will look closely for any unwanted side effects and check how comfortable the jab is for patients.
A key part of the research involves checking antibody levels. When you receive a vaccine, your immune system learns to make antibodies, which act like tiny shields against the virus. By taking blood samples at set times, the research team can count these antibodies and see if this particular formula offers good, lasting protection.
The findings from this study will help scientists decide whether this vaccine formulation should move forward into larger trials. In the long run, research like this helps ensure that future UK booster programmes have access to the safest and most effective options available.
Key takeaways
- This is an early-stage Phase I study testing a new COVID-19 booster recipe.
- The study checks how safe the jab is and how well it triggers protective antibodies.
- Open to adults aged 18 and older of any sex.
- Taking part involves clinic visits, a booster jab, and routine blood tests.
- Participation is entirely voluntary, and you can leave at any time.
Who may be eligible?
This trial is open to men and women aged 18 and older. Because it is an early-stage study looking at booster vaccines, researchers are looking for general adults who are interested in contributing to medical research.
While the main requirement is being at least 18 years old, the study team will also review your medical history. People with certain ongoing health conditions, active infections, or allergies to vaccine ingredients might not be able to join. You may also need to have had specific COVID-19 vaccines in the past to be eligible for a booster.
Every trial has a detailed checklist to make sure participants stay safe. If you are interested, the local research team can talk you through the exact requirements and see if the study is a good match for you.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- I am aged 18 or over.
- I am willing to receive a COVID-19 booster injection.
- I am able to attend regular clinic visits for check-ups and blood tests.
- I do not have a known severe allergy to vaccine ingredients.
- I am happy to discuss my past medical history and vaccine record with the study team.
What does participation involve?
If you decide to take part, you will first attend a screening visit. The study team will explain the trial, answer your questions, and check your general health before you agree to join. If you are eligible, you will receive the booster injection in your upper arm.
After the jab, you will be asked to stay at the clinic for a short time so nurses can check that you feel well. Over the following weeks and months, you will return for several clinic visits. During these visits, doctors will check your health and take small blood samples to measure your antibody levels. You might also be asked to keep a simple symptom diary at home. Total participation usually lasts several months to monitor your immune system over time.
Potential risks and benefits
Locations (1)
- —UnverifiedFinland
Common questions
Can this trial vaccine give me COVID-19?
No. The vaccine cannot give you COVID-19 because it does not contain the live virus.
Will taking part cost me anything?
No, the study medication and tests are provided for free. Many trials also help cover travel expenses to and from the clinic.
What happens if I change my mind after starting?
You are free to leave the trial at any time. You do not need to give a reason, and your regular medical care will not change.
How many clinic visits will I need to make?
The exact number depends on the study schedule, but it usually involves an initial visit for the jab and a few follow-up appointments for blood tests.
Will my GP know that I am taking part?
Yes, with your permission, the research team will let your GP know so your medical records remain up to date.
How to find out more
Always speak to your GP or specialist before deciding to take part in a study.
Interested in taking part?
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.